Rhiannon Price, Pharmacist at King Edward Memorial Hospital.[/caption]
Caspar Townsend MPS, Pharmacist at Perth Children's Hospital compounding unit[/caption]
Iraq Doali, NSW-based locum pharmacist and content creator[/caption]
Normalisation is medical misogyny and delays diagnosis
Sharnelle Vella, ABC Radio Melbourne breakfast co-host[/caption]
Mike Stephens, Director, Medicines policy and Programs at the National Aboriginal Community Controlled Health Organisation (NACCHO)[/caption]
Chastina Heck MPS, Chair of the PSA/NACCHO Aboriginal and Torres Strait Islander Pharmacy Practice Community of Specialty Interest (CSI).[/caption]
Philippa Chigeza, pharmacist at Logan Hospital.[/caption]
COVID-19 rollout strategy recalibrated
Pfizer is now the COVID-19 vaccine of choice for some at-risk patients and those under 50 years of age in priority groups.
NIP access (almost) guaranteed
The state's major parties have committed to allowing pharmacist immunisers to access the National Immunisation Program (NIP) for the first time.
How pharmacists can support patients with dementia
Nicola Sander MPS, a dementia support pharmacist in regional South Australia, will share her experience at PSA25 in August.
PSA’s up-to-date COVID-19 advice for pharmacists
As the number of COVID-19 cases continues to rise in Australia, PSA is working to ensure pharmacists’ needs are considered in pandemic planning.
Future health series: pharmacy can adjust the sails
It’s no longer plain sailing in Australian community pharmacy. Bruce Annabel helps navigate in this, the fourth instalment of our Future Health series.
Most...
Action needed to improve medicine safety in disability care
Barriers to medicine safety show a health system failing to properly support Australians with a disability, a new report from PSA reveals.
